Israel - English - Ministry of Health

medison pharma ltd - zanubrutinib - capsules - zanubrutinib 80 mg - • brukinsa is indicated for the treatment of adult patients with mantle cell lymphoma (mcl) who have received at least one prior therapy.• brukinsa is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm).• brukinsa is indicated for the treatment of adult patients with relapsed or refractory marginal zone lymphoma (mzl) who have received at least one anti-cd20-based regimen.• brukinsa is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll) or small lymphocytic lymphoma (sll).

Malta - English - Medicines Authority

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - fluvastatin - hard capsule - fluvastatin 20 mg - lipid modifying agents

Malta - English - Medicines Authority

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - fluvastatin - hard capsule - fluvastatin 40 mg - lipid modifying agents

Canada - English - Health Canada

beigene switzerland gmbh - zanubrutinib - capsule - 80mg - zanubrutinib 80mg - antineoplastic agents

Canada - English - Health Canada

bayer inc - levonorgestrel - insert (extended-release) - 19.5mg - levonorgestrel 19.5mg - contraceptives

Canada - English - Health Canada

bayer inc - levonorgestrel - insert (extended-release) - 52mg - levonorgestrel 52mg - contraceptives

Singapore - English - HSA (Health Sciences Authority)

beigene singapore pte. ltd. - zanubrutinib - capsule - zanubrutinib 80mg